Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human papillomavirus type 11 major capsid protein L1 (HPV-11 L1) is the primary structural protein of the HPV-11 viral capsid, which encapsulates the viral double-stranded DNA genome. The L1 protein self-assembles into pentameric capsomeres, 72 of which form the icosahedral capsid of the virion. Biologically, HPV-11 L1 mediates the initial attachment of the virus to host cell surfaces by binding to heparan sulfate proteoglycans on basal layer keratinocytes, initiating a conformational change that facilitates viral entry via endocytosis. HPV-11 is a low-risk human papillomavirus type primarily associated with benign epithelial lesions, most notably genital warts (condylomata acuminata) and recurrent respiratory papillomatosis. Recombinant HPV-11 L1 proteins are capable of spontaneously assembling into non-infectious virus-like particles (VLPs) that retain the native antigenicity of the virion. These VLPs serve as the active antigenic components in prophylactic vaccines, such as the quadrivalent (Gardasil) and 9-valent (Gardasil 9) HPV vaccines. Vaccination with these VLPs induces a robust, type-specific neutralizing antibody response that prevents subsequent HPV-11 infection and its associated clinical manifestations.
Active immunization by inducing neutralizing antibodies against HPV-11 L1, preventing viral attachment and entry into host cells
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human papillomavirus type 11 major capsid protein L1 (HPV-11 L1).